Lv41
550 积分 2023-04-25 加入
Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape
15分钟前
已完结
Targeting the Immunoglobulin IGSF9 Enhances Antitumor T-cell Activity and Sensitivity to Anti–PD-1 Immunotherapy
20天前
已完结
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus
28天前
已完结
PD-1–targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer
1个月前
已完结
The anti-angiogenic basis of metronomic chemotherapy
2个月前
已完结
Clinical pharmacokinetics of bevacizumab in patients with solid tumors
2个月前
已完结
Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer
2个月前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
3个月前
已完结
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
3个月前
已完结
Engineering IL-2 for immunotherapy of autoimmunity and cancer
3个月前
已完结
Role of the proline-rich disordered domain of DROSHA in intronic microRNA processing
2年前
已采纳
Aging Fly Cell Atlas identifies exhaustive aging features at cellular resolution
2年前
已采纳
Aging Fly Cell Atlas identifies exhaustive aging features at cellular resolution
2年前
已采纳
Driving Mental Fatigue Classification Based on Brain Functional Connectivity
2年前
已采纳
Antigen presentation by cardiac fibroblasts promotes cardiac dysfunction
2年前
已采纳
Infection-targeted bactericidal nanoparticles
2年前
已采纳
Liver cancer stem cell markers: Progression and therapeutic implications
2年前
已采纳
皖公网安备34019202002308
